These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 16407639

  • 1. Double-blind, randomised, controlled trial assessing controller medications in asthma.
    Shah AR, Sharples LD, Solanki RN, Shah KV.
    Respiration; 2006; 73(4):449-56. PubMed ID: 16407639
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J, Guerra F, Cuevas F, Gutierrez JP, Soto-Ramos M, Anderton S, Mechali D, Chan R, Pedersen S.
    Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
    [Abstract] [Full Text] [Related]

  • 3. A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma.
    Evans DJ, Taylor DA, Zetterstrom O, Chung KF, O'Connor BJ, Barnes PJ.
    N Engl J Med; 1997 Nov 13; 337(20):1412-8. PubMed ID: 9358138
    [Abstract] [Full Text] [Related]

  • 4. Comparisons of the complementary effect on exhaled nitric oxide of salmeterol vs montelukast in asthmatic children taking regular inhaled budesonide.
    Buchvald F, Bisgaard H.
    Ann Allergy Asthma Immunol; 2003 Sep 13; 91(3):309-13. PubMed ID: 14533665
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical trial of low-dose theophylline and montelukast in patients with poorly controlled asthma.
    American Lung Association Asthma Clinical Research Centers.
    Am J Respir Crit Care Med; 2007 Feb 01; 175(3):235-42. PubMed ID: 16998094
    [Abstract] [Full Text] [Related]

  • 15. Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma.
    Price DB, Hernandez D, Magyar P, Fiterman J, Beeh KM, James IG, Konstantopoulos S, Rojas R, van Noord JA, Pons M, Gilles L, Leff JA, Clinical Outcomes with Montelukast as a Partner Agent to Corticosteroid Therapy (COMPACT) International Study Group.
    Thorax; 2003 Mar 01; 58(3):211-6. PubMed ID: 12612295
    [Abstract] [Full Text] [Related]

  • 16. Addition of montelukast versus double dose of inhaled budesonide in moderate persistent asthma.
    Yildirim Z, Ozlu T, Bulbul Y, Bayram H.
    Respirology; 2004 Jun 01; 9(2):243-8. PubMed ID: 15182276
    [Abstract] [Full Text] [Related]

  • 17. A randomized study comparing the effect of loratadine added to montelukast with montelukast, loratadine, and beclomethasone monotherapies in patients with chronic asthma.
    Lu S, Liu N, Dass SB, Reiss TF.
    J Asthma; 2009 Jun 01; 46(5):465-9. PubMed ID: 19544166
    [Abstract] [Full Text] [Related]

  • 18. Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma.
    Szefler SJ, Baker JW, Uryniak T, Goldman M, Silkoff PE.
    J Allergy Clin Immunol; 2007 Nov 01; 120(5):1043-50. PubMed ID: 17983871
    [Abstract] [Full Text] [Related]

  • 19. Montelukast, compared with fluticasone, for control of asthma among 6- to 14-year-old patients with mild asthma: the MOSAIC study.
    Garcia Garcia ML, Wahn U, Gilles L, Swern A, Tozzi CA, Polos P.
    Pediatrics; 2005 Aug 01; 116(2):360-9. PubMed ID: 16061590
    [Abstract] [Full Text] [Related]

  • 20. Comparative efficacy of once-daily therapy with inhaled corticosteroid, leukotriene antagonist or sustained-release theophylline in patients with mild persistent asthma.
    Yurdakul AS, Taci N, Eren A, Sipit T.
    Respir Med; 2003 Dec 01; 97(12):1313-9. PubMed ID: 14682413
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.